Navigation Links
Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
Date:4/16/2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)... Ortho-McNeil Neurologics, a,division of Ortho-McN...,that the U.S. Food and Drug Administration (FDA) ...topiramate), based on studies submitted in,respons...he use of TOPAMAX,in pediatric patients aged 1 to ...on to granting pediatric exclusivity, the FDA is c...
(Date:7/24/2008)...re/ -- There are a record 301,new medicines being ...,report released here today during a briefing that...lnesses have on patients, their families,and soci...million American,adults. The briefing, led by the ...ca (PhRMA), featured Emmy Award-winning actor Joey...
(Date:7/24/2008)...e body temperature, for home,and clinical use, WE...z-Med, Inc.,(subsidiary of American Scientific Res...ributor of the Thermofocus(R) 5-in-1 non-contact,t...a clinical study,conducted by the Second Children,...ly, which proves that the Thermofocus(R) measures ...
(Date:7/23/2008)...apy to Treat the Disease -, WAYNE, N.J. and EMERY...ayer HealthCare Pharmaceuticals and Onyx Pharmaceu...he New England Journal of Medicine published,resul...) (sorafenib),tablets decreased the absolute risk ...le hepatocellular carcinoma (HCC), or liver cancer...
Breaking Medicine Technology:FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 2FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 3More Than 300 New Medicines Being Developed for Mental Illnesses 2More Than 300 New Medicines Being Developed for Mental Illnesses 3More Than 300 New Medicines Being Developed for Mental Illnesses 4Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6Some Epilepsy Patients Are Good Candidates for Surgery 183 1Some Epilepsy Patients Are Good Candidates for Surgery 183 2GERD Not Limited to Grownups 181 1GERD Not Limited to Grownups 181 2GERD Not Limited to Grownups 181 3Anadys Pharmaceuticals Appoints Steve Worland Ph D as President and Chief Executive Officer 181 1Anadys Pharmaceuticals Appoints Steve Worland Ph D as President and Chief Executive Officer 181 2Anadys Pharmaceuticals Appoints Steve Worland Ph D as President and Chief Executive Officer 181 3Social parasites of the smaller kind 150 1Social parasites of the smaller kind 150 2
...lo., June 11, 2007 /PRNewswire/ -- Accera, Inc.,to...n of its Phase,IIb clinical trial of AC-1202 (Keta...s Association,s International Conference on,Preven...th the,findings of earlier clinical and preclinica...nificantly improve the memory and,cognition of sub...
....--(BUSINESS WIRE)--Jun 12, 2007 - Critical,Therap...blication,of data from a pivotal Phase III clinica...e tablets in the June 2007 issue of the,Journal of...d Drug,Administration (FDA) on May 30, 2007. Criti...artner Dey, L.P. (DEY), expects to,begin marketing...
Other Medicine Technology:Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 2Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 3Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 4Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 2Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 3Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 4Critical Therapeutics Announces the Publication of Data for ZyfloCR,(Zileuton) Extended-Release Tablets in the Journal of Asthma 5
(Date:7/25/2008)... HOUSTON, July 25 /PRNewswire/ -- The Elekta Famil...cancer treatment solutions at the 2008,American As...meeting,demonstrating how the joint forces of Ele...iation therapy planning and delivery solutions tha...ter experience for,patients, as well as enhance cl...
(Date:7/25/2008)...urday can be toughest for those trying to drop pou...althDay News) -- Anyone who has avoided Monday mor...nds are not a dieter,s friend. , Now, researche...s about weekends being their undoing: Most people ...ng to lose weight. , "Weekend indulgences can w...
(Date:7/25/2008)... The Drug Information Associ...FDA) will host the Critical Path Initiative (CPI) ...r 15 -16; Bethesda, MD) and the Critical Path Tran.... , Horsham, PA (PRWEB) J... Information Association (DIA)] and the Food and D...
(Date:7/24/2008)... Hoag to lease hospital faci... Newport Beach, CA (Vocus) July 24, 2008 -- Hoa...reement with HCP, Inc. (NYSE: HCP), a Real Estate ...to lease its 175-bed hospital facility on Sand Can..., , , ,The facility is currently operated by Tene...
Breaking Medicine News(10 mins):Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:Weekends Tough on the Diet 2Health News:Weekends Tough on the Diet 3Health News:DIA And FDA To Host Two Important Critical Path Workshops 2Health News:DIA And FDA To Host Two Important Critical Path Workshops 3Health News:Hoag Hospital Announces Agreement to Open Irvine Campus 2
...euroscientists at Harvard Medical School and its a...o stress hormone in mice directly results in the a...issue of Behavioral Neuroscience, which is publish...iation, has this article. This would be helpful i...
...hwarz Pharma AG under which it would be acquiring ...drug that can be a treatment option for an overact...ing condition that affects up to 100 million peopl...ice chairman of Pfizer Inc and president, Pfizer H...
...ed deeply about fat cells, called adipocytes which...arch has now revealed that these Fat cells around ...heart disease. University of Iowa researchers have...cals that can cause inflammation. Fat cells, once...
...government a confirmed case of mad-cow disease in ...case was of a 6-year-old dairy cow which was ident...urveillance program for mad-cow disease. In a writ...es not affect the safety of Canadian beef. Tissues...
Other Medicine News:Health News:Link Between Stress Hormone And Depression Revealed 2Health News:Fat cells lethally connected to heart disease 2
... IOL power calculation software. All A-scans and A...e module with SRK II, SRKT, Holladay Dioptimum and...H 5100e are equipped with corneal compression dete...eadings. The only A-Scan in the world with corneal...
The AccuSonic A-scan makes it easy to obtain extreme accuracy and improved patient outcomes. Obtain accurate measurements with industry leading signal acquisition and processing.
The UD-1000 incorporates the latest ultrasound technology for eyecare specialists. It is the ideal choice for your modern diagnostic laboratory. The UD-1000 combines a powerful B-sector scan system w
The UD-6000 combines all the functions of modern ultrasound diagnostics used in ophthalmology: The latest generation high resolution A/B-sector scanner, a diagnostic A-mode scanner with an optional p
Medicine Products: